Aged Garlic Extract: A New Compound to Shield Aging Muscles

News
#1

AgedGarlic
AgedGarlic2752×1536 445 KB

Research published in Cell Metabolism (2026) reveals that a specific metabolite found in aged garlic extract, S-1-propenyl-L-cysteine (S1PC) , acts as a molecular “linker” that recharges the body’s systemic energy regulation. Unlike generic supplements, S1PC triggers a precise signaling cascade starting in the fat tissue that ultimately boosts muscle strength and reduces frailty by communicating directly with the brain.

The “Big Idea” centers on eNAMPT , a critical enzyme responsible for the biosynthesis of nicotinamide adenine dinucleotide (NAD) , a coenzyme essential for cellular energy and longevity. As we age, circulating eNAMPT levels decline, leading to reduced NAD in the hypothalamus—the brain’s command center for metabolic tone. This study demonstrates that S1PC binds to a protein called LKB1 in white adipose tissue, enhancing its ability to form a complex that activates SIRT1 , a well-known longevity protein. This activation forces fat cells to secrete eNAMPT-laden extracellular vesicles into the bloodstream.

The impact of this relay is systemic. In aged mice, this surge in eNAMPT specifically targeted the hypothalamus, which in turn increased sympathetic nervous system signaling to the skeletal muscles. The result was a significant increase in muscle force and a restoration of body temperature to youthful levels, effectively lowering the mice’s “frailty index”.

Crucially, the researchers translated these findings to humans. In a double-blind, placebo-controlled trial, S1PC administration increased circulating eNAMPT levels in middle-aged individuals, though this effect was dependent on having a healthy amount of body fat. This suggests that the “fat-to-brain-to-muscle” pathway is a conserved mechanism that could be harnessed to combat sarcopenia and age-related decline in the elderly.

Actionable Insights

  • Aged Garlic Extract (AGE) vs. Raw Garlic: The bioactive compound S1PC is relatively abundant in aged garlic extract but not raw garlic. Consumers seeking this specific benefit should prioritize AGE supplements.

  • Adipose Tissue as a Longevity Organ: Systemic NAD health is partially dependent on white adipose tissue (WAT). In the human trial, individuals with a BMI below 18.5 (underweight) did not see the same eNAMPT boost as those with healthy fat mass. Maintaining healthy adiposity is a prerequisite for S1PC’s efficacy.

  • Synergy with NAD Boosters: The study found that combining S1PC with Nicotinamide Mononucleotide (NMN) significantly enhanced circulating eNAMPT levels compared to either compound alone. Biohackers already using NMN or NR may find S1PC a potent “force multiplier” for systemic NAD availability. [Confidence: Medium]

  • Targeting Frailty: S1PC specifically improved high-frequency muscle force and reduced frailty scores in mice. This indicates potential utility for aging populations experiencing muscle weakness (sarcopenia) rather than those seeking acute athletic performance gains. [Confidence: Medium]

Context

Related Reading:

4 Likes
#2

The Translational Protocol

  • Human Equivalent Dose (HED): The mouse dose utilized for healthspan improvements was 5 mg/kg. Using Body Surface Area (BSA) normalization (FDA/ICH guidance):

    • Formula: Human Dose (mg/kg) = Animal Dose (mg/kg) × (Animal Km / Human Km)
    • Math: 5 mg/kg × (3 / 37) = 0.405 mg/kg
    • Total Daily Dose (70 kg Adult): ~28.35 mg.
    • Clinical Alignment: The human trial in this study used 25 mg per dose, which aligns with the calculated HED for a 60–70 kg individual.

  • Pharmacokinetics (PK/PD):

    • Absorption: Rapid. In humans, plasma concentrations increase quickly, reaching approximately 4.14 μM within 120 minutes of oral administration.
    • Distribution: In mice, S1PC distributes to the brain, gastrocnemius muscle, and white adipose tissue (WAT) within 15 minutes.
    • Bioavailability/Half-life: Plasma levels in mice decline rapidly after the 15-minute peak. Human half-life is not explicitly detailed beyond the 120-minute observation window.

  • Safety & Toxicity:

    • Animal Safety: No toxicity was detected in mice after oral administration of 1,000 mg/kg for 2 weeks.
    • NOAEL/LD50: Formal NOAEL (No Observed Adverse Effect Level) and LD50 (Lethal Dose) values were not established, though the 1,000 mg/kg mouse dose suggests a high safety margin (approx. 200x the therapeutic dose).
    • Clinical Safety: Single doses of 25 mg in humans (n=40) were well-tolerated with no reported adverse effects.
    • Organ Signals: No adverse liver or kidney signals were reported; notably, S1PC did not stimulate lipolysis (no increase in free fatty acids) in humans.

Biomarker Verification

Target engagement can be verified via the following downstream changes:

  1. Primary Engagement: Increase in circulating eNAMPT-EVs (Extracellular Vesicle-contained extracellular nicotinamide phosphoribosyltransferase).

  2. Adipose Engagement: Increased phosphorylation of SIRT1 (Ser615) in white adipose tissue (requires biopsy).

  3. Physiological Signature: Restoration of rectal/core body temperature and increased grip strength or muscle force frequency.

Feasibility & ROI

  • Sourcing: Currently not commercially available as a standalone pure compound. The researchers produced a specific 17% S1PC-enriched garlic powder for the study. While Aged Garlic Extract (AGE) contains S1PC, standard retail concentrations are significantly lower than the levels required for the 25 mg dose.

  • Cost vs. Effect:

    • Estimated Cost: High, if attempting to reach 25 mg S1PC via standard AGE (likely requiring excessive volume).
    • Marginal Gain: In mice, the ROI is high for frailty reduction and skeletal muscle force. In humans, ROI for long-term muscle function remains speculative pending multi-dose trials.
1 Like
#3

Based on the study by Suzuki et al. (2026), the following effect sizes were observed for the garlic-derived metabolite S-1-propenyl-L-cysteine (S1PC) across molecular, physiological, and clinical metrics.

Effect Sizes in Mice

The study utilized both acute single-dose (5 mg/kg) and long-term dietary administration (8 months) in aged mice.

Molecular & Cellular Metrics:

  • LKB1 Complex Formation: In differentiated adipocytes, S1PC increased the amounts of co-immunoprecipitated STRAD by 62% and MO25 by 77% compared to controls.

  • SIRT1 Activation: S1PC introduction led to an approximately 30% increase in the serine phosphorylation of SIRT1 at the 30-minute time point.

  • Hypothalamic NAD+: In young mice, hypothalamic NAD+ levels increased from approximately 425 to 480 pmol/mg (~13% increase) within 30 minutes of oral administration.

Physiological & Functional Metrics (Aged Mice):

  • Frailty Index (FI) Score: Long-term treatment significantly reduced the FI score from approximately 0.25 to 0.20 (a ~20% reduction in accumulated deficits).

  • Skeletal Muscle Force: At high-frequency electrical stimulation (200 Hz), muscle force in aged mice increased from approximately 310 mN to 360 mN (a ~16% improvement).

  • Body Temperature: Rectal temperature was restored from a senescent level of approximately 36.5°C to a more youthful level of 37.3°C.

Effect Sizes in Humans

The human clinical trial evaluated the acute effects of a single 25 mg dose of S1PC in subjects aged 20–49.

  • Circulating eNAMPT Levels: In the subgroup of healthy middle-aged individuals (age ≥ 40, BMI ≥ 18.5), S1PC increased relative plasma eNAMPT levels by approximately 1.3-fold (30% increase) compared to baseline at the 120-minute mark.

  • S1PC Plasma Concentration: Reached an average peak concentration of 4.14 μM at 120 minutes post-ingestion.

  • Statistical Correlation: The increase in circulating eNAMPT at 120 minutes showed a statistically significant correlation with Body Mass Index (R^2 = 0.2994, p = 0.0153).

Summary Table of Major Benefits

Metric Species Effect Size (Approx.)
LKB1 Complex (STRAD) Mouse (Cell)
+62%
LKB1 Complex (MO25) Mouse (Cell)
+77%
Frailty Index Reduction Mouse (Aged)
-20%
Muscle Force (200 Hz) Mouse (Aged)
+16%
Circulating eNAMPT Human (Age ≥ 40)
+30%

Puchasing Options:

As of May 7, 2026, the market for standardized aged garlic extract (AGE) is primarily dominated by the Kyolic® brand (Wakunaga of America), which pioneered the proprietary 20-month cold-aging process. While clinical research released today identifies S1PC (S-1-propenyl-L-cysteine) as a critical bioactive metabolite for muscle health and longevity, most commercial products continue to use SAC (S-allyl cysteine) as the primary standardization marker.

The following table identifies the lowest-cost sources for aged garlic extract capsules available in the USA, prioritizing high-volume standardized formulas.

Top 10 Lowest-Cost Standardized Aged Garlic Extract Capsules (USA)

Rank Product/Brand Name Vendor Total Weight (Original & Grams) Total Price (USD) Cost Per 25mg (AGE)
1 Kyolic Formula 100 Original, 300 Caps iHerb 300 caps (300mg/cap) = 90g $26.18 $0.0073
2 Kyolic Formula 104 Cholesterol, 300 Caps iHerb 300 caps (300mg/cap) = 90g $32.66 $0.0091
3 Kyolic Reserve Formula 200, 120 Caps iHerb 120 caps (600mg/cap) = 72g $27.56 $0.0096
4 Micro Ingredients Odorless AGE, 300 Softgels iHerb 300 caps (250mg/cap) = 75g $26.99 $0.0090
5 Kyolic Formula 100 Original, 300 Caps Target 300 caps (300mg/cap) = 90g $34.99 $0.0097
6 Kyolic Formula 102 Cleanse, 200 Veggie Caps iHerb 200 caps (300mg/cap) = 60g $26.09 $0.0109
7 Kyolic Formula 107 Phytosterols, 240 Caps Walmart 240 caps (300mg/cap) = 72g $44.17 $0.0153
8 Kyolic Formula 109 BP Health, 240 Caps iHerb 240 caps (200mg/cap) = 48g $60.71 $0.0316
9 Kyolic Formula 103 Immune, 100 Caps Target 100 caps (220mg/cap) = 22g $16.99 $0.0193
10 NOW Odorless Garlic Extract, 100 Softgels iHerb 100 caps (25mg/cap*) = 2.5g $7.73 $0.0773

*Note: NOW Foods “Odorless Garlic” uses a 20:1 concentrate that equals roughly 500mg of raw garlic, but the extract weight itself is lower per unit than Kyolic standardized formulas.

Shipping & Availability Notes

  • iHerb: Free shipping on orders over $30.00. Orders below this threshold incur a flat rate of approximately $5.00–$7.00.
  • Target: Free shipping on orders over $35.00 or free for Target RedCard holders.
  • Walmart: Free shipping on orders over $35.00; otherwise, shipping is approximately $6.99.
  • S1PC Identification: While research confirms S1PC is a major constituent of all Kyolic AGE products, standard retail labels do not yet list S1PC milligram amounts as of May 2026. Kyolic remains the only brand explicitly referenced in the S1PC studies as providing the necessary metabolite profile.
5 Likes
#4

I recommend considering Life Extension Aged Black Garlic. One capsule is standardized at 0.5% S-Allyl-Cysteine (2.5 mg.). The last time I looked at their documentation, Kyolic formulations ranged between 0.6 mg and 1.8 mg. Beyond the technical documentation, one capsule of the Life Extension formulation had an immediate lowering effect on my BP that I did not experience with Kyolic formulations. (My first experience with Kyolic was more than 20 years ago using the liquid that was supplied with the empty caps to fill.)

LE may be more expensive, though: 30 caps for ~$17 but it goes on sale periodically. Shipping included with cumulative discounts added)

1 Like
#5

For those wondering about the leap: In the aging of garlic, both SAC and S1PC are produced via the hydrolysis of their respective precursors, gamma-glutamyl-S-allyl-L-cysteine and gamma-glutamyl-S-1-propenyl-L-cysteine. Based on the analytical fingerprints of high-potency extracts (such as the Garlzac or ABG10+), the ratio of SAC to S1PC typically ranges from 3:1 to 5:1. Applying the ratio a 2.5 mg SAC dose suggests an S1PC level of approximately 0.75 +/= given some lesser contributions, a safe range might be 0.50 mg to 0.85 mg. Indicative but not determinative.

2 Likes
#6

With ca 0.75 mg S1PC per capsule this means around 35 caps to get to the 25 mg of S1PC in the human trial.

2 Likes
#7

Yes - exactly. Here is the response to my Gemini Pro query about the measured amounts of S1PC in typical Aged Garlic Extracts. It seems likely that a new product with higher levels is likely to be forthcoming from this company.

As of May 2026, there is no commercial label evidence for a standardized amount of S1PC (S-1-propenyl-L-cysteine) in retail Aged Garlic Extract (AGE) capsules. However, there is significant scientific and company-provided evidencefrom Wakunaga Pharmaceutical researchers (the primary manufacturers of AGE) that quantifies S1PC in relation to other markers.

1. Scientific Quantification (The “Similar to SAC” Rule)

Peer-reviewed research and reviews authored by Wakunaga scientists—notably Kodera et al. (2020)—provide the most direct evidence for S1PC levels in standard Aged Garlic Extract:

  • The Concentration Benchmark: S1PC is virtually absent in raw garlic but increases during the 20-month aging process. Research indicates that the concentration of S1PC eventually increases to levels “almost similar to S-allyl-L-cysteine (SAC)” , the primary standardization marker for Kyolic® products.

  • The Numbers: In standard commercial Kyolic® formulations (like Formula 100), a 600 mg dose of AGE powder typically contains approximately 0.6 mg to 1.5 mg of SAC (0.1% to 0.25% by weight). Based on the “similar to SAC” rule, a standard serving of 2 capsules likely provides 0.6 mg to 1.5 mg of S1PC.

2. Clinical Dose vs. Commercial Dose

The recent study (Suzuki et al., 2026) highlights a significant translational gap between standard supplements and the effective clinical dose for muscle health:

  • Study Dose: The human clinical trial used an “S1PC-enriched garlic powder” providing 25 mg of S1PC per dose.
  • Commercial Availability: The study explicitly states that this 17%-enriched powder was produced specifically for the study and is not currently commercially available.
  • Extrapolation: To reach the 25 mg clinical dose using standard commercial capsules (est. 1.5 mg S1PC per serving), an individual would theoretically need to consume approximately 17 servings (34 capsules) per day.

3. Company-Provided Technical Evidence

While not on the Supplement Facts panel, Wakunaga Holdings Co., Ltd. provides technical documentation and has moved to protect the compound:

  • Trademarks: Wakunaga holds the registered trademark for S1PC™ in the U.S. and Japan, indicating its role as a proprietary bioactive target.
  • Chemistry Data: Technical bulletins from the company identify S1PC as one of the four “major sulfur-containing amino acids” in AGE, alongside SAC, SAMC, and SMC.
  • Production Benchmarks: In the 2026 study, the researchers noted that their intermediate production step (before final concentration to 17%) yielded a powder with 0.6% S1PC—roughly 3–6 times higher than standard commercial grade.

Summary Table: S1PC Concentration Evidence

Source Product Form S1PC Content (Est.) Status
Retail Labels Kyolic Formula 100/104 Not Listed Commercial
Kodera et al. (2020) Standard AGE Powder ~0.1% – 0.25% Scientific Baseline
Suzuki et al. (2026) Intermediate Powder 0.6% Research-Only
Suzuki et al. (2026) Clinical Trial Tablet 17% (25 mg) Research-Only

Strategic Takeaway: While standard Aged Garlic Extract is a source of S1PC, the “muscle-protective” dose identified in recent research is roughly 15–20 times higher than what is found in a standard daily serving of the company’s current commercial capsules. Specialized “S1PC-standardized” products are expected but not yet on the retail market.

3 Likes
#8

I checked on this, and wanted to know the S1PC levels.

Here is the Gemini Pro response:

Based on the clinical chemistry of black garlic and the manufacturing specifications for the Life Extension product, here is the breakdown of the S1PC (S-1-propenyl-L-cysteine) content.

1. Estimated S1PC Content

While the Life Extension Aged Black Garlic (using the Garlzac® extract) is standardized to 2.5 mg of SAC , the S1PC level is not explicitly standardized or listed on the label. However, we can calculate a highly probable range based on the known chemical profile of black garlic extract:

  • The S1PC-to-SAC Ratio in Black Garlic: Unlike the “Aged Garlic Extract” (AGE) from Wakunaga (which uses a 20-month cold-aging process that yields a 1:1 ratio of SAC to S1PC), Black Garlic is produced through high-heat fermentation. Research indicates that in heat-treated black garlic, SAC accumulates much more aggressively than S1PC.
  • Calculated Estimate: Analytical studies of commercial black garlic extracts show that S1PC levels typically range from 10% to 15% of the SAC content.
    • Low Estimate: 0.25 mg S1PC per capsule (10% of SAC).
    • High Estimate: 0.38 mg S1PC per capsule (15% of SAC).

2. Comparison to the Longevity Study Dose

The 2026 Suzuki et al. study, which identified the “fat-to-brain-to-muscle” longevity pathway, established specific dosage benchmarks that differ significantly from this supplement’s profile:

Metric Life Extension (1 Cap) Suzuki et al. (Clinical Dose)
S1PC Content ~0.25 – 0.38 mg (Est.) 25.0 mg
SAC Content 2.5 mg ~25.0 mg (Approx. 1:1 ratio)
Extract Type Fermented Black Garlic Cold-Aged Extract (AGE)

3. Actionable Intelligence for Sourcing

  • The “Gap” in Black Garlic: Because black garlic relies on high heat (Maillard reaction), it is an excellent source of SAC for cardiovascular health but a relatively poor source of S1PC for the muscle-protective pathways identified in the latest research.
  • Product Fit: If your primary goal is cardiovascular health (blood pressure and cholesterol), the 2.5 mg of SAC in the Life Extension product is a clinically validated and effective dose.
  • Biohacker Note: To achieve the 25 mg S1PC dose identified for muscle longevity using this specific Life Extension product, you would theoretically need to consume 65 to 100 capsules daily. This would result in a massive intake of SAC (160–250 mg), which, while generally safe, has not been studied at those levels in humans.

Conclusion: For those specifically targeting the S1PC-LKB1-SIRT1 pathway for muscle health, this product is significantly under-dosed. You would require a cold-aged extract (like Kyolic) or a future S1PC-enriched powder, as the fermentation process used in black garlic inherently prioritizes SAC over S1PC.

3 Likes
#9

This is interesting on two levels. First, those of us who wish to experiment with S1PC may want to await the appearance of a commercial product with a higher concentration of the substance. Second, I checked my ratios with paid versions of GPT, Claude, and Gemini. Gemini Pro does not seem to be responding at the moment but its response yesterday is summarized in my previous post.

Based on the following prompt (plus my standard meta-prompt structuring depth, separating confidence levels, etc.). Claude and GPT made a few interesting points.

Specific Prompt
Is there a way to draw a reasonable inference as to the S1PC level (or range) of an aged black garlic product in which a 500 mg capsule contains 2.5 mg of S-allyl-cysteine?

Most Interesting Portion of Claude’s Response
The cleanest comparator dataset is Woo, Cha, Kang & Kyung (Food Sci Biotechnol 2022), which paired SAC and S1PC measurements across commercial Korean black garlic products:

  • Whole BG cloves: SAC 22.3–63.7 mg/100 g; S1PC 2.2–16.6 mg/100 g → S1PC:SAC roughly 0.05–0.35, mid-range ~0.15–0.20
  • Liquid BGE: SAC 0.31–27.2 mg/100 mL; S1PC ND–3.68 mg/100 mL → ratio 0–~0.15, with S1PC frequently below the LOD

Compare against Wakunaga-style aged garlic extract (Kodera et al., Molecules 2017), made by 10–18+ month aqueous/ethanolic aging at room temperature, where S1PC accumulates "almost up to the level similar of SAC" — i.e., ratio ~0.7–1.0. The split is mechanistically sensible: γ-GSAC and γ-GS1PC both hydrolyze to their free cysteinyl derivatives during aging, but the higher-temperature Maillard process used for black garlic appears to degrade S1PC (and SAC, via reaction with reducing sugars) faster than cold aqueous aging does. The Sanguansri/Thai work (Sci Rep 2022) explicitly shows SAC declining 4–7× after the first week at 60–80°C as Maillard chemistry consumes it; S1PC behavior is less well-characterized but is widely thought to be at least as labile.

Inference for your product

Assuming the label “aged black garlic” denotes the conventional Maillard/heat process (60–90°C, 60–90% RH, 2–6 weeks) rather than long-aged aqueous AGE:

  • Most plausible range: 0.25–1.0 mg S1PC per 500 mg (i.e., S1PC:SAC of 0.10–0.40)
  • Point estimate: ~0.4–0.5 mg S1PC per 500 mg (ratio ~0.18, the rough centroid of the BG cloves dataset)
  • Wider envelope to capture processing variability and the “ND in some BGE” tail: ~0.05–1.5 mg per 500 mg

If the product happens to be a Wakunaga-AGE-style preparation that the marketer has labeled “black garlic” in the looser consumer sense, the answer would shift dramatically to ~1.7–2.5 mg S1PC per 500 mg. Worth checking the label or the manufacturer for the aging method (temperature, duration, solvent) — that single piece of information collapses most of the uncertainty.

Speculative considerations (flagged per your preference)

A few inferences that go beyond what the data strictly support but I think are reasonable:

  1. The fact that the product is standardized to 2.5 mg SAC suggests the manufacturer cares about the SAC marker but probably did not optimize for S1PC retention. Speculatively, this nudges the estimate toward the lower end of the range (S1PC:SAC ≈ 0.10–0.20), because aggressive heat/concentration steps that maximize SAC concentration per gram of finished product will tend to take a disproportionate toll on the more thermolabile S1PC.
  2. There is a real possibility of S1PC being near or below the LOD in the finished product. The Woo et al. data showed several BGE products with non-detectable S1PC despite measurable SAC — this is the failure mode I’d actually be most worried about if S1PC bioactivity (immunomodulation, BP reduction in SHR models, peripheral circulation effects from the Wakunaga group) is what you’re after.
  3. If you want to constrain the inference further without commissioning analytical work: the γ-GSAC/γ-GS1PC ratio in the raw garlic is a useful upstream check, since these are the precursors. Most cultivars run γ-GSAC > γ-GS1PC by a factor of ~1.5–3, which by itself would predict S1PC ≤ SAC in any well-behaved aging process; the heat-aging penalty then pushes S1PC further below SAC.

Most Interesting Portion of GPT’s Response
Life Extension’s product page and supplement facts identify this as 500 mg Garlzac® aged black garlic extract standardized to 0.5% S-allyl-cysteine, i.e., 2.5 mg SAC per capsule. Olene’s Garlzac page similarly describes the extract as standardized to >0.5% SAC.

The question is the S1PC:SAC ratio. The best available inference comes from measured aged-garlic supplement data. In a 2024 LC-MS study of commercial aged garlic supplements, only 42% contained measurable S1PC; most S1PC-positive products had S1PC below 3% of SAC, the reference aged black garlic extract was 11% of SAC, and a few unusual products reached 72–93% of SAC, apparently linked to nonconventional processing or questionable composition profiles.

Using those ratios:

Assumption about S1PC:SAC ratio Implied S1PC per 500 mg capsule
Near absent / trace ~0 to 0.025 mg
1–3% of SAC 0.025–0.075 mg
7–11% of SAC 0.175–0.275 mg
15% of SAC 0.375 mg
40–50% of SAC 1.0–1.25 mg
Rare high-ratio outlier, 72–93% 1.8–2.3 mg

Beyond these specifics, I think I’m seeing snippets of reportage based on company marketing material in some of these LLM responses.

1 Like